Sarah Cannon Research Institute shared a post on LinkedIn:
“Can AI personalize cancer treatment?
David R. Spigel, President & Chief Medical Officer at Sarah Cannon Research Institute and medical oncologist at SCRI Oncology Partners, shares insights on how artificial intelligence is shaping the future of oncology, from targeted therapies to immune-based breakthroughs.
Learn more in this NewsChannel 5 Network segment.”
More posts about Sarah Cannon Research Institute.